Impression Healthcare

A cannabinoid medicines development company undertaking extensive clinical programs, guided by our medical advisory board.


Therapeutic products under development have no existing pharmacotherapy treatments available to patients, representing global market opportunities.


Clinical programs are informed by existing bodies of research, underpinning our procession to in-human trials.

Further to our clinical programs, Impression also has its Australian licenses in place to import, export and distribute medicinal cannabis products.

We’ve launched our own line of EU GMP approved cannabinoid oils under the brand name, “INCANNEX”.

Our cannabinoid oils are sold through a product supply and distribution relationship with Cannvalate Pty Ltd, which is the largest network of cannabis prescribers in Australia.

INCANNEX formulations have been designed to match those product-types that are most in-demand.

Board and Management

Impression Healthcare logo

Want The Latest From IHL?

Join our investor mailing list to be notified of announcements when they are made and sent all the latest investor materials as they are published. 

Thanks for signing up! We'll be in touch shortly.